病毒介导的免疫抑制在头癌中的作用
Sayuri Miyauchi1,2, Souvick Roy1,2, Nathalie Boutros1,2
1Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA, USA.
Oncogene
|March 13, 2025
概括
人类乳头瘤病毒 (HPV) 和爱斯坦-巴尔病毒 (EBV) 使用免疫逃避策略来促进头癌. 了解这些病毒机制,特别是HPV E5,是有效免疫疗法的关键.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 头癌是全球重要的健康问题,病毒感染起着关键作用.
- 人类乳头瘤病毒 (HPV) 是口腔癌的主要原因,而爱斯坦-巴尔病毒 (EBV) 是鼻癌的主要原因.
- 这些病毒采用复杂的免疫逃避策略来促进疾病的发展.
研究的目的:
- 审查和合成HPV和EBV在头癌中使用的免疫逃避机制.
- 突出HPV上蛋白E5在持续感染和癌症进展中的关键作用.
- 探索这些病毒免疫抑制策略对检查点封锁免疫疗法的疗效的影响.
主要方法:
- 文献综述和对病毒瘤发生和免疫学现有研究的综合.
- 专注于HPVE5,E6和E7上蛋白所使用的免疫逃避的特定机制.
- 在鼻癌的背景下分析EBV的免疫抑制策略.
主要成果:
- HPV和EBV编码coproteins,并利用各种机制来逃避宿主免疫监测.
- 鉴定出HPV E5是确定持久性感染和驱动癌症发展的关键因素.
- 病毒免疫抑制策略与对当前免疫疗法的耐药性有关,影响患者的治疗结果.
结论:
- 病毒感染,特别是HPV和EBV,是通过免疫逃避发展头癌的关键.
- 向像HPV E5这样的病毒瘤蛋白可能提供新的治疗策略.
- 了解这些病毒免疫逃生机制对于改善头癌治疗和免疫疗法反应至关重要.
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Immunodeficiency Diseases
884
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
884
Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Cell-mediated Immune Responses
66.6K
Overview
66.6K


